Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

RCPT

RECEPTOS, INC. (RCPT)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RCPT
DataOraFonteTitoloSimboloCompagnia
13/07/201515:55The Motley Fool5 Drugs That Investors May Be UndervaluingNASDAQ:RCPT(MM)
02/07/201518:11The Motley FoolWhy Shares in Receptos Soared 15% in JuneNASDAQ:RCPT(MM)
12/06/201500:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RCPT(MM)
11/06/201522:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RCPT(MM)
02/06/201515:06Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:RCPT(MM)
01/06/201523:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RCPT(MM)
15/05/201514:00GlobeNewswire Inc.Receptos Announces Oral Plenary Presentation of TOUCHSTONE Phase 2 Induction Data at Digestive Disease Week 2015NASDAQ:RCPT(MM)
14/05/201514:00GlobeNewswire Inc.Receptos to Present at UBS Global Healthcare ConferenceNASDAQ:RCPT(MM)
07/05/201514:00GlobeNewswire Inc.Receptos to Present at Bank of America Merrill Lynch 2015 Healthcare ConferenceNASDAQ:RCPT(MM)
06/05/201522:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RCPT(MM)
06/05/201516:28Analyst Ratings NetworkReceptos PT Raised to $202.00 (RCPT)NASDAQ:RCPT(MM)
05/05/201522:01GlobeNewswire Inc.Receptos Provides Business Update and Reports First Quarter 2015 Financial ResultsNASDAQ:RCPT(MM)
29/04/201514:00GlobeNewswire Inc.Receptos to Hold First Quarter 2015 Results Conference CallNASDAQ:RCPT(MM)
19/04/201517:07The Motley Fool3 Biotech Stocks That Could Be Developing Billion Dollar DrugsNASDAQ:RCPT(MM)
17/04/201522:10Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:RCPT(MM)
17/04/201522:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RCPT(MM)
16/04/201514:00GlobeNewswire Inc.Receptos Reports Positive Results for the Maintenance Period of the Phase 2 TOUCHSTONE Trial of Ozanimod in Ulcerative Coliti...NASDAQ:RCPT(MM)
01/04/201523:25The Motley FoolWhy Receptos, Inc. Shares Soared Higher TodayNASDAQ:RCPT(MM)
01/04/201514:00GlobeNewswire Inc.Receptos Completes Enrollment of RADIANCE Phase 3 Trial of Ozanimod in Relapsing Multiple SclerosisNASDAQ:RCPT(MM)
09/03/201513:00GlobeNewswire Inc.Receptos to Present at Barclays Global Healthcare ConferenceNASDAQ:RCPT(MM)
03/03/201522:01GlobeNewswire Inc.Receptos Provides Development Updates and Reports Fourth Quarter and Year End 2014 Financial ResultsNASDAQ:RCPT(MM)
02/03/201513:57Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RCPT(MM)
26/02/201514:00GlobeNewswire Inc.Receptos to Hold Fourth Quarter and Year End 2014 Financial Results Conference CallNASDAQ:RCPT(MM)
18/02/201514:00GlobeNewswire Inc.Receptos Announces Oral Podium Presentation at Annual Meeting of European Crohn's and Colitis Organization (ECCO)NASDAQ:RCPT(MM)
17/02/201518:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RCPT(MM)
13/02/201521:29Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RCPT(MM)
09/02/201514:00GlobeNewswire Inc.Receptos to Present at Leerink Global Healthcare ConferenceNASDAQ:RCPT(MM)
22/12/201414:00GlobeNewswire Inc.Receptos Initiates SUNBEAM Phase 3 Trial of RPC1063 in Relapsing Multiple SclerosisNASDAQ:RCPT(MM)
19/11/201422:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:RCPT(MM)
14/11/201414:00PR Newswire (US)Tocagen Appoints Faheem Hasnain as Chairman of the Board of DirectorsNASDAQ:RCPT(MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RCPT

La tua Cronologia

Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network